|
|
|
Volumn 54, Issue 7 SUPPL., 1994, Pages
|
|
Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCYSTEINE;
ACETYLSALICYLIC ACID;
ANTIMUTAGENIC AGENT;
ANTINEOPLASTIC AGENT;
ANTIOXIDANT;
BETA CAROTENE;
CARBENOXOLONE;
CURCUMIN;
ELLAGIC ACID;
FINASTERIDE;
GLYCYRRHETINIC ACID;
IBUPROFEN;
ISOTRETINOIN;
OLTIPRAZ;
PHENHEXYL ISOTHIOCYANATE;
PIROXICAM;
PRASTERONE;
PROSTATE SPECIFIC ANTIGEN;
RETINOL;
S ALLYLCYSTEINE;
SULINDAC;
TAMOXIFEN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER INHIBITION;
CANCER PREVENTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
UTERINE CERVIX CARCINOMA IN SITU;
ADENOMA;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE II;
COHORT STUDIES;
COLONIC NEOPLASMS;
COLORECTAL NEOPLASMS;
FEMALE;
HUMANS;
MALE;
MOUTH NEOPLASMS;
NEOPLASMS;
PROSTATIC NEOPLASMS;
RESEARCH DESIGN;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
URINARY BLADDER NEOPLASMS;
UTERINE NEOPLASMS;
|
|
EID: 0028346953
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (146)
|
|
References (104)
|
